| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 46.449 | 41.313 | 45.140 | 35.001 | 35.012 | 28.988 |
| Total Income - EUR | - | - | - | - | 46.449 | 43.314 | 45.140 | 35.443 | 35.012 | 29.044 |
| Total Expenses - EUR | - | - | - | - | 1.119 | 5.901 | 11.986 | 6.829 | 6.127 | 9.609 |
| Gross Profit/Loss - EUR | - | - | - | - | 45.330 | 37.412 | 33.154 | 28.615 | 28.885 | 19.435 |
| Net Profit/Loss - EUR | - | - | - | - | 43.936 | 36.206 | 31.827 | 27.564 | 24.818 | 16.481 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Endodiagnost S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 47.119 | 40.325 | 34.921 | 28.884 | 22.670 | 17.421 |
| Current Assets | - | - | - | - | 466 | 43.771 | 75.129 | 104.222 | 123.413 | 141.840 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 2.001 | 740 | 3.673 | 7.196 | 7.738 |
| Cash | - | - | - | - | 466 | 41.770 | 74.389 | 9.299 | 25.244 | 3.430 |
| Shareholders Funds | - | - | - | - | 43.979 | 79.350 | 109.418 | 131.238 | 142.583 | 158.267 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 3.606 | 4.745 | 633 | 1.868 | 3.500 | 994 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endodiagnost S.r.l.